Atlas Trials

Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study

Clinical trial NCT04218136 · UNKNOWN

Trial details

NCT number
NCT04218136
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Study type
OBSERVATIONAL
Head and Neck Cancer
Start date
2019-12-26
Primary completion
2022-04-28
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.